Industries – Life sciencesPharma and bioprocessing

We empower clients to combine technology with sustainable practices, helping them manufacture high-quality products more efficiently.

The pharma and bioprocessing sector is undergoing significant change, driven by the increasing demand for personalised medicine, complex biologics and sustainable manufacturing practices. Companies face mounting pressure to streamline operations, integrate digital technologies and ensure compliance with stringent regulatory standards.

We work alongside pharmaceutical manufacturers, bioprocessing companies and biotech innovators to develop transformative solutions that address these challenges. From designing advanced manufacturing systems to integrating automation and data analytics, we help clients optimise efficiency and accelerate product development timelines.

We provide end-to-end support or contribute expertise at key stages of the development lifecycle, ensuring every product meets the highest standards for safety, quality and environmental responsibility.

Let us help you lead and shape the future of biotech innovation.

RNA vaccine

Small-batch RNA vaccine manufacturing system

42T has collaborated with a start-up developing their deployable ‘biofoundry’ system to improve cleanability, reliability, ease of use, and yield.

economics in healthcare

The economics of healthcare

Since the influx of spending caused by the COVID pandemic, healthcare investment has been on a rapid, followed by a steady decline. But it’s a decline that will return spending to a pre-pandemic, albeit low, baseline. 

Let us help you

Our multidisciplinary team specialises in device development, simulation, human factors engineering and regulatory gap analysis.